InvestorsHub Logo
Followers 14
Posts 85
Boards Moderated 0
Alias Born 12/11/2010

Re: None

Saturday, 08/03/2019 8:15:03 PM

Saturday, August 03, 2019 8:15:03 PM

Post# of 329589
Bioelectronics has entered into a license and supply agreement. This is a done deal! Signed, sealed and delivered. The impending announcement of the company or should I say partner, will be disclosed shortly. This so called company or partner reaches out to over sixty-thousand OTC outlets. That’s who it is! Guess who it is? LOL

My understanding is that upon contracts being inked, a cheque (Canadian spelling) must be issued to BIEL for the initial order.

THE FEE!
There is also the license fee! Now what is the fee based on? The fee is usually based upon the costs that the company accumulated bringing the product to market. The costs include trials, FDA, soft costs and other expenses that were incurred. Plus a little incentive for BIEL. Now pending on the size of market the partner takes on would be the ratio of what the fee would be. This will be no desperate measure from BIEL to just take any amount offered to them. It’s all numbers.

I don’t think too much of the selloff yesterday, one’s loss is also one’s gain.

Talk to you all after the announcement.